Podcast
Questions and Answers
What is the first objective mentioned in the text?
What is the first objective mentioned in the text?
- Define when to initiate pharmacotherapy for weight loss as an adjunct to lifestyle therapy.
- Identify the three components of evidence-base lifestyle therapy.
- Calculate a patient’s body mass index (BMI).
- Define overweight and obesity. (correct)
Which guideline is mentioned as a clinical resource in the text?
Which guideline is mentioned as a clinical resource in the text?
- ACC/AHA/TOS Overweight and Obesity Guidelines (correct)
- Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
- AACE/ACE Clinical Practice Guideline for Medical Care of Patients with Obesity
- CDC's Guidelines for Obesity Management
What is the recommended resource for review in the text?
What is the recommended resource for review in the text?
- AACE/ACE Clinical Practice Guideline for Medical Care of Patients with Obesity
- Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
- MyPlate from US Dept of Agriculture: myplate.gov
- Sheehan A, Chen JT, Yanovski JA. Obesity. In: DiPiro JT, Yee GC, Haines ST, Nolin TD, Ellingrod VL, Posey L. eds. DiPiro’s Pharmacotherapy: A Pathophysiologic Approach, 12th Edition (correct)
What is the date of access for the CDC's New Adult Obesity Maps?
What is the date of access for the CDC's New Adult Obesity Maps?
What is the overarching goal of the text?
What is the overarching goal of the text?
What is the primary focus of the Objectives mentioned in the text?
What is the primary focus of the Objectives mentioned in the text?
What is the recommended website for dietary guidance mentioned in the text?
What is the recommended website for dietary guidance mentioned in the text?
When should pharmacotherapy for weight loss be initiated according to the text?
When should pharmacotherapy for weight loss be initiated according to the text?
What is the primary focus of the Clinical Guidelines mentioned in the text?
What is the primary focus of the Clinical Guidelines mentioned in the text?
What is the purpose of calculating a patient’s body mass index (BMI) as mentioned in the text?
What is the purpose of calculating a patient’s body mass index (BMI) as mentioned in the text?
Which factor is NOT mentioned as a contributor to obesity?
Which factor is NOT mentioned as a contributor to obesity?
What is the recommended duration for moderate to vigorous activity most days per week for promoting weight loss and cardiometabolic health?
What is the recommended duration for moderate to vigorous activity most days per week for promoting weight loss and cardiometabolic health?
Which of the following is a criterion for Metabolic Syndrome associated with obesity?
Which of the following is a criterion for Metabolic Syndrome associated with obesity?
What is the main tool used to classify obesity?
What is the main tool used to classify obesity?
Which of the following is NOT recommended for nutrition in the management of obesity?
Which of the following is NOT recommended for nutrition in the management of obesity?
What is the general weight loss goal through diet and exercise in 6-12 months?
What is the general weight loss goal through diet and exercise in 6-12 months?
Which medication is NOT mentioned as a potential cause of drug-induced weight gain?
Which medication is NOT mentioned as a potential cause of drug-induced weight gain?
What is the overall goal for exercise in promoting weight loss and cardiometabolic health?
What is the overall goal for exercise in promoting weight loss and cardiometabolic health?
What does obesity increase the risk of, along with an increased risk of morbidity from chronic diseases such as diabetes and cardiovascular diseases?
What does obesity increase the risk of, along with an increased risk of morbidity from chronic diseases such as diabetes and cardiovascular diseases?
What is the main driving factor contributing to obesity according to the text?
What is the main driving factor contributing to obesity according to the text?
Which medication may lead to increased heart rate, dry mouth, and constipation?
Which medication may lead to increased heart rate, dry mouth, and constipation?
What adverse effects are commonly associated with GLP-1 receptor agonists?
What adverse effects are commonly associated with GLP-1 receptor agonists?
What are common adverse effects of naltrexone/bupropion?
What are common adverse effects of naltrexone/bupropion?
What is a common adverse effect of orlistat?
What is a common adverse effect of orlistat?
What is a key focus of behavioral therapy for obesity management?
What is a key focus of behavioral therapy for obesity management?
What is the efficacy goal for pharmacotherapy in obesity management at 3 months?
What is the efficacy goal for pharmacotherapy in obesity management at 3 months?
What BMI criteria are considered for bariatric surgery?
What BMI criteria are considered for bariatric surgery?
What type of bariatric surgery involves vertical-banded gastroplasty?
What type of bariatric surgery involves vertical-banded gastroplasty?
What are potential complications of bariatric surgery?
What are potential complications of bariatric surgery?
What is a requirement for candidates for bariatric surgery?
What is a requirement for candidates for bariatric surgery?
Flashcards are hidden until you start studying
Study Notes
Obesity Management Interventions: Behavioral Therapy, Pharmacotherapy, and Bariatric Surgery
- Behavioral therapy involves a comprehensive lifestyle program focusing on behavior modification, goal setting, and self-monitoring
- Pharmacotherapy includes the use of medications such as sympathomimetic agents, GLP-1 receptor agonists, phentermine/topiramate ER, naltrexone/bupropion, and orlistat
- Sympathomimetic agents like phentermine have common adverse effects including increased blood pressure/heart rate and constipation
- GLP-1 receptor agonists like liraglutide and semaglutide can cause nausea/vomiting and increased risk of pancreatitis and gallbladder disease
- Phentermine/topiramate ER may lead to increased heart rate/blood pressure, dry mouth, and constipation
- Naltrexone/bupropion can cause nausea/vomiting, headache, and increased heart rate/blood pressure
- Orlistat may result in common adverse effects like abdominal pain, flatulence, and fecal urgency or incontinence
- Monitoring factors for pharmacotherapy include efficacy goal of ≥5% weight loss at 3 months and safety/tolerability assessments
- Bariatric surgery is considered for individuals with a BMI ≥40 kg/m2 or ≥35 kg/m2 with obesity-related comorbidities
- Bariatric surgery can lead to surgical complications, nutrient deficiencies, and changes in drug absorption
- Types of bariatric surgery include vertical-banded gastroplasty, adjustable gastric banding, and Roux-en-Y gastric bypass
- Candidates for bariatric surgery should be motivated to lose weight and have insufficient weight loss with behavioral therapy ± pharmacotherapy
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
